ACEM Pharmacology Flashcards
(372 cards)
Mechanism of action of atropine
a competitive reversible muscuranic ACh receptor antgonist
Anticholinergic activity
equally powerful at M1 M2 M3 receptors
minimal effect of nicotinic receptors
Pharmacokinetics of atropine
Administration: IV oral topical nebulized/inhaled
Distribution: wide Vd including into CNS
Metabolism and excretion: Half life is 2 hours, 60% is excreted unchanged via kidneys. 40% undergoes phase I and phase II metabolism and then renally excreted
Organ effects of atropine
Eye - mydriasis and cycloplegia
CNS delerium decreased tremor in parkinsons
CVS tachycardia
Resp bronchodilation and decreased secretions
GIT decreased saliva decreased gastric acid secretion decreased mucin production delayed gastric emptying decreased gut motility
Urinary relaxes ureteric and bladder wall smooth muscle urine retention
Skin decreased sweating
Clinical use of atropine
Treatment of symptomatic bradycardia or bradyarrhythmias
in opthalmology for mydriasis (dilate pupils)
occasionally used in RSI in paediatrics
drying of secretions in palliative patients
travellers diarrhoea
Atropine toxicity effects
Agitation, delirium
raised temperature
blurred vision, mydriasis
flushed skin
dry mouth
tachycardia
(mad as a hatter, blind as bat, red as a beet, dry as a bone)
What is the mechanism of action of indirectly acting cholinomimetics
(acetylcholinesterase inhibitors)
inhibit acetylcholinesterase enzyme
increasing concentration of Ach in the vicinity of cholinoreceptors
action on both nicotinic and musarinic receptors
what type of indirectly acting cholinomimetics (acetylcholinesterase inhibitors) are there ?
Reversible - neostigmine, physostigmine, pyridostigmine
Irreversible - organophosphates and insecticides
Cardiovascular effects of Indirectly acting cholinomimetics (acetylcholinesterase inhibitors)
Both sympathetic and parasympathetic ganglia can be activated
Parasympathetic effects generally predominate -
bradycardia, decreased CO, decreased contractility
OVerdose may cause tachycardia and hypotension
Pharmacokinetics of Adrenaline?
Administration; IV, IM, subcut, nebulised. Poor oral absorption
Distribution: Crosses the placenta, does not cross blood brain barrier. 50% protein bound. Onset within seconds, duration 2 mins
Metabolism: terminated by metabolism in sympathetic nerve terminals by COMT and MAO. Circulating adrenaline metabolised by COMT
Elimination: metabolites excreted in urine
Pharmacodynamics of adrenaline?
Equal effects on alpha and beta receptors
Alpha - vasoconstriction
Beta1 - positive inotropic and chronotropic effects
Beta2 - smooth muscle relaxation in airways and skeletal muscle
Effects of adrenaline on other organs?
Respiratory - bronchodilation
Eyes - pupil dilation, decreased IOP and production of aqueous humour
Gastric smooth muscle - relaxation
Genitourinary - bladder smooth muscle relaxation
Liver - enhanced glycolysis
Increased production of sweat at apocrine glands
What receptors does noradrenaline act on ?
Predominantly alpha 1 - vascular smooth muscle constriction
some alpha 2 beta 1 and beta 2
How does noradenaline increase blood pressure?
Increase in both systolic and diastolic blood pressure
Alpha 1 activity - vasoconstriciton, increased peripheral resistance = increased diastolic pressure
Beta 1 activity - increased myocardial contractility = increased systolic BP
What effect does noradrenaline have on heart rate ?
Minimal change
Beta 1 increases heart rate
however,
compensatory baroreceptor reflex causes decrease in HR
Mechanism of action metaraminol ?
Direct alpha 1 agonist - vascular smooth muscle constriction
Classes of local anaesthetics
Aminoamides - Lignocaine, Bupivocaine, prilocaine
Aminoesters - procaine, benzocaine, tetracaine
Mechanism of action of lignocaine
Sodium channel blocker
Class 1B antiarrhytmic
Local anaesthetic
Blocks voltage gated sodium channels without altering the resting membrane potential
Toxic effects of Lignocaine
CNS; perioral or tongue numbness, metallic taste > nystagmus, tinnitus, muscle twitching, nausea, vomiting > seizures, sedation
CVS; arrhythmias, hypotension, worsening CCF
GIT; vomiting anorexia nausea
Haem; methaemoglobinaemia (increase in MetHb, become blue), most often with prilocaine
Mechanism of action of nitrous
Modulates GABA-A recetpors
Increased dynorphin release
NMDA agonist
low solubilty in the blood so reaches arterial tension rapidly, rapid equilibrium in the brain, fast onset and fast recovery
Organ effects of nitrous
CNS; analgesia amnesia increased cerebral blood flow
Renal; decrease GFR increased renal vascular resistance
CVS; dose dependent mycardial depression
Resp; reduced response to CO2 and hypoxia
GI; nausea, vomiting
Pharmacokinetics of propofol
Administration; IV only
Distribution; rapid onset and recover is driven by redistribution of the drug from the brain to other areas. Half life 2-4 minutes, elimination half life up to 25 mins
Metabolism; rapidly metabolised in the liver
Elimination; Excreted in the urine as inactive metabolites
Usual induction dose of propofol
1-2.5mg/kg in adults
2.5-3.5mg/kg in paediatrics
Clinical effects of propofol
Anaesthesia/sedation
no analgesia
Transient apnoea
Decreased BP
anti-emetic properties
Adverse effects of Propofol
Hypotension
Apnoea
pain on injection
allergy/anaphylaxis
propofol infusion syndrome (a metabolic acidosis)